Update on Rivaroxaban

Update on Rivaroxaban

Show other versions (1)

Anticoagulants are recommended for the prevention and treatment of venous thromboembolism (VTE). The new anticoagulants which target specific factors in the coagulation cascade offer the advantage that they can be administered orally. These drugs seek to offer safe anticoagulation without the need f...

Full description

Bibliographic Details
Main Authors:	Osama Moussa, Dipankar Chattopadhyay, Vish Bhattacharya
Format:	Article
Language:	English
Published:	SAGE Publishing 2010-01-01
Series:	Clinical Medicine Insights: Blood Disorders
Online Access:	https://doi.org/10.4137/CMBD.S5101

Similar Items

Update on Rivaroxaban
by: Osama Moussa, et al.
Published: (2010-11-01)

Rivaroxaban in atrial fibrillation cardioversion: an update
by: Lavalle C, et al.
Published: (2019-05-01)

Rivaroxaban monograph
by: Teerapat Nantsupawat, et al.
Published: (2015-04-01)

Rivaroxaban: Drug review
by: Abhishek Kumar Singh, et al.
Published: (2020-01-01)

Rivaroxaban in atrial fibrillation
by: Giorgi MA, et al.
Published: (2012-08-01)

Rivaroxaban and Hemostasis in Emergency Care
by: Jürgen Koscielny, et al.
Published: (2014-01-01)

Effects of ticagrelor on the pharmacokinetics of rivaroxaban in rats
by: Jia Chong, et al.
Published: (2020-01-01)

Rivaroxaban for the treatment of cerebral venous thrombosis
by: Sara Esmaeili, et al.
Published: (2021-02-01)

Intracranial hemorrhage in patient treated with rivaroxaban
by: Michelle Molina, et al.
Published: (2014-03-01)

Idiosyncratic Liver Injury due to Rivaroxaban
by: Aneesh Cherakulam Ratheendran, et al.
Published: (2017-12-01)

Intravesicular Onabotulinumtoxin A Hemorrhage on Rivaroxaban
by: Allison Eubanks, et al.
Published: (2019-01-01)

Hemomediastino en tomador de rivaroxaban
by: Pablo Ruiz-Sada, et al.
Published: (2016-12-01)

Demeanor of rivaroxaban in activated/inactivated FXa
by: Kaname Seki, et al.
Published: (2017-03-01)

Life-Threatening Hemopericardium Associated with Rivaroxaban
by: Sijan Basnet, et al.
Published: (2017-01-01)

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
by: Jan Beyer-Westendorf, et al.
Published: (2019-04-01)

Bleeding Complication of Triple Therapy of Rivaroxaban, Prasugrel, and Aspirin: A Case Report and General Discussion
by: Dane D. Gruenebaum, et al.
Published: (2014-01-01)

Rivaroxaban: striking two birds with one stone
by: Yae Min Park
Published: (2021-07-01)

Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban
by: Lien Thi Ngo, et al.
Published: (2020-10-01)

Rivaroxaban for the treatment of saphenous vein graft thrombosis
by: Konstantinos Marmagkiolis, et al.
Published: (2016-07-01)

Fatigue after initiating rivaroxaban for venous thromboembolism
by: Tina Margrethe Karlsvik, et al.
Published: (2020-05-01)

Spontaneous Spinal Epidural Hematoma from Rivaroxaban
by: Charlotte Goldfine, et al.
Published: (2018-05-01)

Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
by: Minsoo Kim, et al.
Published: (2019-03-01)

Rivaroxaban for the treatment of saphenous vein graft thrombosis
by: Konstantinos Marmagkiolis, et al.
Published: (2016-07-01)

Angioedema due to the new oral anticoagulant rivaroxaban
by: Cihan Altin, et al.
Published: (2014-01-01)

A Case of Rivaroxaban Associated Intracranial Hemorrhage
by: Jean Chin-Yu Lo, et al.
Published: (2014-07-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery
by: Antonijević Nebojša, et al.
Published: (2020-01-01)

Intravenous Thrombolysis in a Stroke Patient Receiving Rivaroxaban
by: Felix Fluri, et al.
Published: (2013-10-01)

The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation
by: Guy A. Richards, et al.
Published: (2018-05-01)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
by: Rupert Bauersachs, et al.
Published: (2020-05-01)

Drug approval processes: A case study of rivaroxaban
by: Sally A Arif, et al.
Published: (2013-01-01)

Thromboprophylaxis for hip and knee surgery: critical appraisal of rivaroxaban
by: Erica Romualdi, et al.
Published: (2010-04-01)

Potential role of rivaroxaban in patients with acute coronary syndrome
by: Fitchett DH
Published: (2012-11-01)

Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy
by: Chen W, et al.
Published: (2017-03-01)

Rivaroxaban: A possible cause of Guillain–Barre syndrome
by: Madhavi Karri, et al.
Published: (2019-01-01)

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
by: Leonie Stolz, et al.
Published: (2017-07-01)

The discovery of rivaroxaban: translating preclinical assessments into clinical practice
by: Dagmar eKubitza, et al.
Published: (2013-11-01)

A study on the role of rivaroxaban in management of venous thromboembolism
by: Mohmed Abdalwahab, et al.
Published: (2015-10-01)

A Novel Synthesis of the Oxazolidinone Antithrombotic Agent Rivaroxaban
by: Jianyong Yuan, et al.
Published: (2014-09-01)

Resolution of Extensive Coronary Thrombosis under Rivaroxaban Treatment
by: Murat Yuksel, et al.
Published: (2015-12-01)